Поисковый запрос: (<.>S=ОТВЕТ НА ЛЕЧЕНИЕ<.>) |
Общее количество найденных документов : 70
Показаны документы с 1 по 20
|
|
1.
| Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens // Brit. J. Haematol., 2005. Vol. 130, N 3.-С.363-372
|
2.
| Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): A therapeutic advances in childhood leukemia (TACL) consortium study // Pediat. Blood and Cancer, 2010. Vol. 55, N 3.-С.421-429
|
3.
| Phase II study of weekly low-dose paclitaxel for relapsed and refractory Non-Hodgkin's lymphoma: A Wisconsin oncology network study // Cancer Invest., 2005. Vol. 23, N 1.-С.13-18
|
4.
| Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens // Brit. J. Haematol., 2005. Vol. 130, N 3.-С.363-372
|
5.
| A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors // Int. J. Cancer, 2012. Vol. 130, N 6.-С.1357-1366
|
6.
| Грабовой А.Н. Гистологическая оценка ответа опухоли на химио-/лучевую терапию // Клинич. онкол., 2012, N 6.-С.138-143
|
7.
| Грабовой А.Н. Гистологическая оценка ответа опухоли на химио-/лучевую терапию // Клинич. онкол., 2012, N 6.-С.138-143
|
8.
| Грабовой А.Н. Гистологическая оценка ответа опухоли на химио-/лучевую терапию // Клинич. онкол., 2012, N 6.-С.138-143
|
9.
| Phase II study of weekly low-dose paclitaxel for relapsed and refractory Non-Hodgkin's lymphoma: A Wisconsin oncology network study // Cancer Invest., 2005. Vol. 23, N 1.-С.13-18
|
10.
| Therapeutic drug monitoring of A77 1726, the active metabolite of leflunomide: Serum concentrations predict response to treatment in patients with rheumatoid arthritis // Ann. Rheum. Diseases, 2005. Vol. 64, N 4.-С.569-574
|
11.
| Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma // Prostate, 2002. Vol. 51, N 4.-С.256-267
|
12.
| Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma // Prostate, 2002. Vol. 51, N 4.-С.256-267
|
13.
| Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma // Prostate, 2002. Vol. 51, N 4.-С.256-267
|
14.
| Значение гистологических изменений в ткани печени для педиатрической практики // Вопр. дет. диетол., 2007. Т. 5, N 1.-С.7-12
|
15.
| Значение гистологических изменений в ткани печени для педиатрической практики // Вопр. дет. диетол., 2007. Т. 5, N 1.-С.7-12
|
16.
| Lerut T. Role of FDG-PET scan in staging of cancer of the esophagus and gastroesophageal junction // Minerva chir., 2002. Vol. 57, N 6.-С.837-845
|
17.
| Lerut T. Role of FDG-PET scan in staging of cancer of the esophagus and gastroesophageal junction // Minerva chir., 2002. Vol. 57, N 6.-С.837-845
|
18.
| A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors // Int. J. Cancer, 2012. Vol. 130, N 6.-С.1357-1366
|
19.
| Robinson M.R.G. Carcinoma of the prostate. Objective criteria of response // Amer. J. Clin. Oncol., 1988. Vol. 11, Suppl. N2.-С.48-52
|
20.
| Респираторные нарушения при полимиозите/дерматомиозите // Соврем. ревматол., 2014, N 1.-С.31-38
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"